Chemokine-dependent B cell-T cell interactions in chronic lymphocytic leukemia and multiple myeloma - targets for therapeutic intervention?
about
Cellular and molecular mechanisms underlie the anti-tumor activities exerted by Walterinnesia aegyptia venom combined with silica nanoparticles against multiple myeloma cancer cell types.Prognostic Value of CD11b Expression Level for Acute Myeloid Leukemia Patients: A Meta-AnalysisAnti-CCR7 therapy exerts a potent anti-tumor activity in a xenograft model of human mantle cell lymphomaAdipocyte-derived players in hematologic tumors: useful novel targets?Characteristics of BAFF and APRIL factor expression in multiple myeloma and clinical significance.Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease.
P2860
Chemokine-dependent B cell-T cell interactions in chronic lymphocytic leukemia and multiple myeloma - targets for therapeutic intervention?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Chemokine-dependent B cell-T c ...... for therapeutic intervention?
@en
Chemokine-dependent B cell-T c ...... for therapeutic intervention?
@nl
type
label
Chemokine-dependent B cell-T c ...... for therapeutic intervention?
@en
Chemokine-dependent B cell-T c ...... for therapeutic intervention?
@nl
prefLabel
Chemokine-dependent B cell-T c ...... for therapeutic intervention?
@en
Chemokine-dependent B cell-T c ...... for therapeutic intervention?
@nl
P2093
P2860
P1476
Chemokine-dependent B cell-T c ...... for therapeutic intervention?
@en
P2093
Claudia Zelle-Rieser
Karin Jöhrer
Richard Greil
Sebastian W Hofbauer
P2860
P304
P356
10.1517/14712598.2012.664128
P407
P577
2012-02-15T00:00:00Z